Skip to content

Palomar/Cynosure Icon

Save device

Non-Ablative Fractional · 1540nm fractional + 2940nm + IPL MaxG

Technology: IPL

Classification & configurations

Category group: Resurfacing & pigment (ablative, fractional, picosecond, vascular)

Current

At a glance

New price
$70k–$100kSource not documented
Used asking price
$20k–$40kSource not documented
FDA status
Supplies & recurring costs
See supply and replacement costs below.
View supply details
Sources and verified data on file

Data on file

Recurring consumables
Not verified
FDA
FDA ClearedK110907, K142376
Used asking prices
Not verified
  • This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
  • Bottle prices and estimates may still appear under Treatment & running costs.
  • The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.

Figures are reference points, not current offers. Used asking prices are not completed-sale values.

Read FDA-cleared indicationsExact wording from 2 FDA records

K110907 (Palomar Medical Technologies, Inc., 2011)

__ _________ (Division Sign-Off) 5 1 (k)Numbr (fknwn) KII907Division of Surgical, Orthopedic, 5 10k) umbe (iknon):Ki 1907and Restorative Devices Palomar IconTM Aesthetic System 510k ubr IIo The 2940 Ablative Laser Handpiece is intended for use in surgical applications requiring the excision, incision, ablation, vaporization, and coagulation of soft tissue. Soft tissue includes skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, calculi or fragments, mucous membrane, lymph vessels and nodes, organs, and glands in the following indications: skin resurfacing, treatment of wrinkles, epidermal nevi, telangiectasia, spider veins, actinic chelitis, keloids, verrucae, skin tags, anal tags, keratoses, scar revision (including acne scars), debulking benign tumors, debulking cysts and superficial skin lesions. The 2940 Fractional Ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia. The 1540 Fractional Non-ablative Laser 1-andpiece is intended for use in coagulation of soft tissue, skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars. The 1440 Fractional Non-ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation of soft tissue and skin resurfacing procedures. The 1540 Fractional Non-ablative Laser and 2940 Fractional Ablative Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions. The 1440 Fractional Non-ablative Laser Handpiece and 2940 Fractional Ablative Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions. The MaxIR Handpiece is intended for photocoagulation of soft tissue in dermatologic applications.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

K142376 (Cynosure, Inc., 2014)

The 2940 Ablative Laser Handpiece is intended for use in surgical applications requiring the excision, incision, ablation, vaporization, and coagulation of soft tissue. Soft tissue includes skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, calculi or fragments, mucous membrane, lymph vessels and nodes, organs, and glands in the following indications: skin resurfacing, treatment of wrinkles, epidermal nevi, telangiectasia, spider veins, actinic chelitis, keloids, verrucae, skin tags, anal tags, keratoses, scar revision (including acne scars), debulking benign tumors, debulking cysts and superficial skin lesions. The 2940 Fractional Ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia. The 1540 Fractional Non-ablative Laser Handpiece is intended for use in the coagulation of soft tissue, skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars. The 1440 Fractional Non-ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation of soft tissue and skin resurfacing procedures. The 1540 Fractional Non-ablative Laser and 2940 Fractional Abaltive Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions. The 1440 Fractional Non-ablative Laser Handpiece and 2940 Fractional Ablative Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularties, dyschromia and pigmented lesions. The MaxIR Handpiece is intended for photocoagulation of soft tissue in dermatologic applications.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

Page updated: September 4, 2026 · How we verify

New and used price references
New$70k–$100k
Source not documented
Used$20k–$40k
Source not documented

Axis runs $0–$100k. Reference figures, not current offers. Used asking prices are not completed-sale values.

Consumable cost per treatment

Not verified

We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.

Price sourcesSources, dates and configurations
New: $70k–$100k·Researched estimate — no dated source on file yet; not a quote.
Used asking range: $20k–$40k·Researched estimate — no dated source on file yet; not a quote.
Key factsCompany, specifications and verification dates
Key facts
ManufacturerPalomar (Cynosure)
CompanyOwner: Hahn & Company (South Korean private equity) (private equity owned, since 2024) · Distribution: direct
Parent companyCynosure Lutronic
Brand ownerPalomar/Cynosure
Built by (OEM)Palomar Medical Technologies
CategoryNon-Ablative Fractional
Technology1540nm fractional + 2940nm + IPL MaxG
FDA statusFDA Cleared
510(k) citationK110907, K142376
New price range$70k–$100k
Used asking range$20k–$40k
ConsumablesNot published
Launch year2013
PricingNot published
Manufacturer-source documents checkedNot published

Overview

Aesthetic multi-platform with Skintel melanin reader

How it worksTechnology and manufacturing

How the technology works

Multi-handpiece platform: Max-series pulsed light with filtered spectra — MaxG (~500-670 + 870-1200nm) for vessels/pigment/photorejuvenation, MaxR/MaxYs for hair removal across skin types; the 1540nm erbium-glass fractional creates dermal microcolumns for wrinkles, acne scars, surgical scars, striae; optional 1064nm Nd:YAG for leg veins and darker-skin hair.

Standard mechanisms: selective photothermolysis + fractional dermal wounding.

Patented technology

MaxG is Palomar's optimized pulsed light — dual-band filtering, sapphire contact cooling, unusually high stable peak power for an IPL, which is why it outperforms commodity IPLs on vessels. Skintel (shared with Vectus) recommends settings from live skin measurement.

Origin

Developed and originally built in Burlington, Massachusetts (Palomar); produced under Cynosure post-2013.

FDA & regulatory detailClearance timeline, authorization route and citation notes
Documented clearance timeline
Documented dates: Clearance 2011, Launch 201320112013

Clearance 2011 · Launch 2013 · K110907; K142376

Authorized via 510(k)

510(k): K110907 and K142376. Checked 4 Sep 2026.

FDA-cleared indications (verbatim)

K110907 (Palomar Medical Technologies, Inc., 2011)

__ _________ (Division Sign-Off) 5 1 (k)Numbr (fknwn) KII907Division of Surgical, Orthopedic, 5 10k) umbe (iknon):Ki 1907and Restorative Devices Palomar IconTM Aesthetic System 510k ubr IIo The 2940 Ablative Laser Handpiece is intended for use in surgical applications requiring the excision, incision, ablation, vaporization, and coagulation of soft tissue. Soft tissue includes skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, calculi or fragments, mucous membrane, lymph vessels and nodes, organs, and glands in the following indications: skin resurfacing, treatment of wrinkles, epidermal nevi, telangiectasia, spider veins, actinic chelitis, keloids, verrucae, skin tags, anal tags, keratoses, scar revision (including acne scars), debulking benign tumors, debulking cysts and superficial skin lesions. The 2940 Fractional Ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia. The 1540 Fractional Non-ablative Laser 1-andpiece is intended for use in coagulation of soft tissue, skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars. The 1440 Fractional Non-ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation of soft tissue and skin resurfacing procedures. The 1540 Fractional Non-ablative Laser and 2940 Fractional Ablative Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions. The 1440 Fractional Non-ablative Laser Handpiece and 2940 Fractional Ablative Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions. The MaxIR Handpiece is intended for photocoagulation of soft tissue in dermatologic applications.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

K142376 (Cynosure, Inc., 2014)

The 2940 Ablative Laser Handpiece is intended for use in surgical applications requiring the excision, incision, ablation, vaporization, and coagulation of soft tissue. Soft tissue includes skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, calculi or fragments, mucous membrane, lymph vessels and nodes, organs, and glands in the following indications: skin resurfacing, treatment of wrinkles, epidermal nevi, telangiectasia, spider veins, actinic chelitis, keloids, verrucae, skin tags, anal tags, keratoses, scar revision (including acne scars), debulking benign tumors, debulking cysts and superficial skin lesions. The 2940 Fractional Ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia. The 1540 Fractional Non-ablative Laser Handpiece is intended for use in the coagulation of soft tissue, skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars. The 1440 Fractional Non-ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation of soft tissue and skin resurfacing procedures. The 1540 Fractional Non-ablative Laser and 2940 Fractional Abaltive Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions. The 1440 Fractional Non-ablative Laser Handpiece and 2940 Fractional Ablative Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularties, dyschromia and pigmented lesions. The MaxIR Handpiece is intended for photocoagulation of soft tissue in dermatologic applications.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

Marketed for

IPL — 1540nm fractional + 2940nm + IPL MaxG

Marketing claims are the manufacturer's own and are not the same as a cleared indication.

Parent company: Cynosure Lutronic

Legal manufacturer: Palomar Medical Technologies (United States)

Applicant on the FDA record

Palomar Medical Technologies / CynosureThe applicant named on the FDA record can differ from the brand shown on the device.

Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.

Treatment & running costs

Treatments

Sessions & timing

No treatment schedule documented yet.

What practices charge

No sourced treatment price on file.

Supplies & recurring costs

Supply pricing is not documented with a dated source yet. Request an itemized supply quote.

Annual service & support

No annual service cost documented yet.

Payback calculatorModel your own volume, labor and service costs

Estimate your payback

Pre-filled from our published Palomar/Cynosure Icon data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.

Start from

No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.

Pre-filled from the midpoint of the published new-price range

20 is an illustrative default — change it to your volume.

No sourced per-session price on file — enter what you charge.

Required — enter your cost; missing data does not mean $0.

Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.

Annual service contract ÷ 12, if you carry one.

Your estimate

Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.

This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.

ComplianceScreening and contraindications on the manufacturer's record

Contraindications & screening

Tanned skin (IPL especially), melasma caution with IPL, isotretinoin, photosensitizers, pregnancy, active infection, light-triggered seizure disorders, keloids for the 1540.

Warranty & serviceWhat to confirm in writing before you buy

Before buying new or used, confirm in writing:

  • Current warranty coverage
  • Included training
  • Service terms

Chains using this device

A chain listing does not establish availability at every location.

No confirmed chain deployments recorded yet.

Owner & operator reviews

Write a review

No owner or operator reviews yet. Be the first →

Current alternatives

Current catalog models to research. Confirm availability and configuration with the supplier.

Solta Fraxel Dual (re:store Dual)

Non-Ablative Fractional · $90k–$120k

Solta Medical Fraxel FTX

Non-Ablative Fractional

History6 tracked changes

Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.

  1. September 4, 2026

    FDA status

    UnknownCleared

    Clearance located on openFDA

    Source: Council round 2 audit, verified on openFDA 2026-09-04

  2. September 4, 2026

    FDA status

    UnknownCleared

    Source: Catalog update

  3. September 4, 2026

    510(k) numbers

    K-number set re-verified against openFDA

    Source: Council round 2 audit, verified on openFDA 2026-09-04

  4. September 4, 2026

    FDA K-numbers

    Source: Catalog update

  5. September 4, 2026

    FDA source URL

    Source: Catalog update

  6. August 1, 2026

    Record created

    Added to The Aesthetic Index — August 2026

    Source: The Aesthetic Index editorial

Cite this data: The Aesthetic Index, "Palomar/Cynosure Icon — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).

Get the full State of Aesthetic Devices 2026 report

A catalog of US-marketed aesthetic and wellness devices — preview it free.

Get the report

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.